Glioblastoma Multiforme (GBM) – Subtype Analysis Lance Parsons.

Slides:



Advertisements
Similar presentations
Normal Anaplastic astrocytoma Glioblastoma Figure S1; Soumya et al., 2009 Malignant astrocytoma Figure S1. One-way hierarchical clustering of.
Advertisements

Affymetrix Gene Expression Microarrays Application to Pulmonary Arterial Hypertension Bob Stearman 02/24/2014.
Capturing Best Practice for Microarray Gene Expression Data Analysis Gregory Piatetsky-Shapiro Tom Khabaza Sridhar Ramaswamy Presented briefly by Joey.
Departments of Medicine and Biostatistics
Clustering short time series gene expression data Jason Ernst, Gerard J. Nau and Ziv Bar-Joseph BIOINFORMATICS, vol
Mutual Information Mathematical Biology Seminar
Gene Expression Data Analyses (3)
‘Gene Shaving’ as a method for identifying distinct sets of genes with similar expression patterns Tim Randolph & Garth Tan Presentation for Stat 593E.
GCB/CIS 535 Microarray Topics John Tobias November 8th, 2004.
Exploring Microarray data Javier Cabrera. Outline 1.Exploratory Analysis Steps. 2.Microarray Data as Multivariate Data. 3.Dimension Reduction 4.Correlation.
Palisades and tumors. Lung metastatic tumor in brain.
GCB/CIS 535 Microarray Topics John Tobias November 15 th, 2004.
Survival analysis. First example of the day Small cell lungcanser Meadian survival time: 8-10 months 2-year survival is 10% New treatment showed median.
A comparative study of survival models for breast cancer prognostication based on microarray data: a single gene beat them all? B. Haibe-Kains, C. Desmedt,
Gene expression profiling identifies molecular subtypes of gliomas
PrognoScan A new database for meta-analysis of the prognostic value of genes 1 Hideaki Mizuno, Kunio Kitada, Kenta Nakai, Akinori Sarai BMC Med Genomics.
CS 548 Spring 2015 Showcase by Pankaj Didwania, Sarah Schultz, Mingchen Xie Showcasing Work by Malhotra, Chau, Sun, Hadjipanayis, & Navathe on Temporal.
Overall agenda Part 1 and 2  Part 1: Basic statistical concepts and descriptive statistics summarizing and visualising data describing data -measures.
A Multivariate Biomarker for Parkinson’s Disease M. Coakley, G. Crocetti, P. Dressner, W. Kellum, T. Lamin The Michael L. Gargano 12 th Annual Research.
Gene Expression Profiling Illustrated Using BRB-ArrayTools.
Radiogenomics in glioblastoma multiforme
Enabling biomarker validation in breast cancer molecular subtypes: sensitivity and specificity of array-based subtype classification in 983 patients Balázs.
Probe-Level Data Normalisation: RMA and GC-RMA Sam Robson Images courtesy of Neil Ward, European Application Engineer, Agilent Technologies.
SIMPLE TWO GROUP TESTS Prof Peter T Donnan Prof Peter T Donnan.
1.DATABASE construction  n=1,715  Median OS=40.0 months, age: 64+/-10 yrs  Histology (adeno/squamous/large): 50% / 45% / 5%  Stage 1/2/3/4: 63% / 27%
BioQUEST / SCALE-IT Module From Omics Data to Knowledge Case 1: Microarrays Namyong Lee Minnesota State University, Mankato Matthew Macauley Clemson University.
Head and Neck Cancer: microRNA analysis
Selection of Patient Samples and Genes for Disease Prognosis Limsoon Wong Institute for Infocomm Research Joint work with Jinyan Li & Huiqing Liu.
Prediction of Glioblastoma Multiforme Patient Time to Recurrence Using MR Image Features and Gene Expression Nicolasjilwan, M.1·Clifford, R.2·Flanders,
Class Prediction and Discovery Using Gene Expression Data Donna K. Slonim, Pablo Tamayo, Jill P. Mesirov, Todd R. Golub, Eric S. Lander 발표자 : 이인희.
Techniques for Analysing Microarrays Which genes are involved in ovarian and prostate cancer?
Prediction of Glioblastoma Multiforme Patient Survival Using MR Image Features and Gene Expression Control/Tracking Number: 11-O-1519-ASNR Nicolasjilwan,
Support Vector Machine Data Mining Olvi L. Mangasarian with Glenn M. Fung, Jude W. Shavlik & Collaborators at ExonHit – Paris Data Mining Institute University.
Application of Class Discovery and Class Prediction Methods to Microarray Data Kellie J. Archer, Ph.D. Assistant Professor Department of Biostatistics.
Nuria Lopez-Bigas Methods and tools in functional genomics (microarrays) BCO17.
1 ArrayTrack Demonstration National Center for Toxicological Research U.S. Food and Drug Administration 3900 NCTR Road, Jefferson, AR
Class 23, 2001 CBCl/AI MIT Bioinformatics Applications and Feature Selection for SVMs S. Mukherjee.
ICNCT-16, June 2014, Helsinki Glioma heterogeneity and the L-Amino acid transporter-1 (LAT1): A first step to stratified BPA-based BNCT? D. Ngoga 1 ; C.
Innovative Paths to Better Medicines Design Considerations in Molecular Biomarker Discovery Studies Doris Damian and Robert McBurney June 6, 2007.
Computational Approaches for Biomarker Discovery SubbaLakshmiswetha Patchamatla.
A comparative study of survival models for breast cancer prognostication based on microarray data: a single gene beat them all? B. Haibe-Kains, C. Desmedt,
Molecular Classification of Cancer Class Discovery and Class Prediction by Gene Expression Monitoring.
Experimental design and power analysis for systems biology Karlyn Beer 21 Aug 2012.
Linear Discriminant Analysis and Logistic Regression.
The Broad Institute of MIT and Harvard Differential Analysis.
Jin MENG Shen FU (DPD 08) Biology 2 - Head/Neck and CNS Tumors
Pan-cancer analysis of prognostic genes Jordan Anaya Omnes Res, In this study I have used publicly available clinical and.
Statistical Analysis for Expression Experiments Heather Adams BeeSpace Doctoral Forum Thursday May 21, 2009.
Date of download: 5/29/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Gene Expression Signatures, Clinicopathological Features,
Introduction to Oncomine Xiayu Stacy Huang. Oncomine is a cancer-specific microarray database and has a web-based data-mining platform aimed at facilitating.
Microarray Technology and Data Analysis Roy Williams PhD Sanford | Burnham Medical Research Institute.
Tumor Heterogeneity: From biological concepts to computational methods Bo Li, PhD Dana Farber Cancer Institute Harvard Statistics Department.
Evaluating the Clinical Outcomes of Sixty-Three Patients Treated with Gamma Knife as Salvage Therapy for Glioblastoma Multiforme Erik W Larson, Halloran.
miRNA-targets cross-talks: key players in glioblastoma multiforme
Figure 1 Unemployment duration elasticity and labour market conditions
C Supplemental Figure S2.. C Supplemental Figure S2.
Functional Genomics Analysis Reveals a MYC Signature Associated with a Poor Clinical Prognosis in Liposarcomas  Dat Tran, Kundan Verma, Kristin Ward,
Part Three. Data Analysis
Differential Expression of Circular RNAs in Glioblastoma Multiforme and Its Correlation with Prognosis  Junle Zhu, Jingliang Ye, Lei Zhang, Lili Xia,
Elizabeth Garrett Giovanni Parmigiani
Class Prediction Based on Gene Expression Data Issues in the Design and Analysis of Microarray Experiments Michael D. Radmacher, Ph.D. Biometric Research.
Volume 29, Issue 5, Pages (May 2016)
Robustness of TRU, Proximal-proliferative (PP), and Proximal-inflammatory (PI) classification. Robustness of TRU, Proximal-proliferative (PP), and Proximal-inflammatory.
Neuropathology at Southmead
Correlation between Pten/p53 status and AKT pathway activity in BC and effect on clinical outcome Box plot for p53‐pathway activity in p53 wild‐type and.
Distinct molecular and clinical correlates of H3F3A mutation subgroups
MiR-520d-3p is an independent positive prognostic factor in ovarian cancer. miR-520d-3p is an independent positive prognostic factor in ovarian cancer.
PD-L1 expression correlates with T-cell markers and an IFN response signature in human melanomas. PD-L1 expression correlates with T-cell markers and an.
One-way hierarchical cluster analysis of SAM-identified genes using the TMEV software to see the data substructure. One-way hierarchical cluster analysis.
Expression of TGFβ ligands in GBM
Presentation transcript:

Glioblastoma Multiforme (GBM) – Subtype Analysis Lance Parsons

Introduction Clinicians (meat readers) determine histological categorization: Astrocytoma, Oligodendrocytoma, Mixed, or Glioblastoma multiforme (GBM) GBM patients have poor prognosis, but some surive unexpectly long. Molecularly and clinically distinct subtypes of GBMs

Tumor Type AstroMixedOligoGBM Age YoungMediumOld Incorporating Biological Knowledge “Tiers” of classification can assist with discovery of downstream groups Glioma Classification –Histological Level –Clinical Level (Survival, Age, etc) –Transcriptiome (Gene Expression Level) Gene Classification –GO Hierarchy –Pathway Databases –Expression Level (Microarray Data) Survival ShortLong Glioma Subtypes ABC Gene Subset Expression XYX

Age and Survival Young patients show greater variability in survival Use this level of the “hierarchy” to assist in downstream analysis. Very simple method is to use only the Young samples and find the groups within that set of samples.

Normalization Making the numbers comparable –Log Transform – Equalize variance, lineraize data –Median Center Arrays – Correct for differences between arrays –Standardize to unit variance?

Noise Filter Removing noise from the dataset –Affymetrix software does some of this with Present/Absent calls –Fold-change filter? –Other methods?

Feature (Gene) Selection Find genes highly correlated with patient survival, within young sample group. Cox Proportional Hazards model –Regression model that accounts for “censored” data Permutation test can improve robustness Simple Cox selects 39 genes (permutation pending)

Exploration of Results The genes we select are statistically significant (as dictated by our Cox testing methodology), but they may not be biologically or clinically significant. Initial exploration through hierarchical clustering.

Clinical Validation Kaplan-Meier curves fit the two groups to a survival model

Biological Validation file:///C:/Documents%20and%20Settings/L ance/My%20Documents/Research/project s/HenryFord/HFAnalysis-GBM- Young_annotations.htmlfile:///C:/Documents%20and%20Settings/L ance/My%20Documents/Research/project s/HenryFord/HFAnalysis-GBM- Young_annotations.html